Transparent Pricing for Long-Term Supply Our pricing model is designed to support recurring procurement by offering consistent quality at accessible price points-without compromise. HOW TO APPLY FOR A QUALIFIED ACCOUNT Complete the Qualified Account Form

Dosage Guidance: Each pen contains 32 mg (16 mg of each peptide) Available doses per injection: 0.25 mg, 0.5 mg, 0.75 mg, or 1 mg Standard protocols involve daily or alternate-day administration depending on research focus For instance, 0.5 mg selected, delivers 0.5 mg BPC157 and 0.5 mg TB500 per dose Injection sites: Abdomen (at least 5cm from navel) Outer thigh Back of upper arm Rotate sites to avoid irritation BPC157 & TB500 36 Suggested Dosage Guidelines Dosing may vary depending on the purpose of the research or recovery objective: Application Area Suggested Dosage Frequency Injury Recovery (muscle, tendon, ligament) 0.75 mg 1 mg Daily Joint & Tendon Inflammation 0.5 mg 0.75 mg Daily Gut Healing / GI Repair 0.25 mg 0.5 mg Daily Post-Surgical Recovery 1 mg Daily General Regeneration / Anti-inflammatory 0.5 mg 0.75 mg Daily or 5x per week Missed dose: If a dose is missed, administer it as soon as possible

A vitamin shot offers long-lasting effects on energy production and endurance and promotes overall good health
It says do not exceed 4 tablets a day
About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS)